VENBIO GLOBAL STRATEGIC FUND IV, L.P. purchased 10.1% of their position (382.35K shares) of ATTOVIA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $6.50M — a moderate purchase. The strongest form of insider conviction signal.
Common Stock
Shares
+2.31M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+822K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+665.15K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+382.35K
Price / share
$17.00
Trade value
$6.50M
% of position
Net shares
+4.18M
Net value
$6.50M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/6/2026 | C · Conversion | +2.31M | — | — | New position | 0.00 | 2.31M |
| Common Stock Direct | 8/6/2026 | C · Conversion | +822K | — | — | 35.6% | 2.31M | 3.13M |
| Common Stock Direct | 8/6/2026 | C · Conversion | +665.15K | — | — | 21.2% | 3.13M | 3.80M |
| Common Stock Direct | 8/6/2026 | P · Purchase | +382.35K | $17.00 | $6.50M | 10.1% | 3.80M | 4.18M |
| Total | +4.18M | $6.50M | ||||||
Series A Preferred Stock
Common Stock
2.31M shares
Shares
−21.48M
Strike price
Held after
0.00
Exercisable
—
Series B Preferred Stock
Common Stock
822K shares
Shares
−7.64M
Strike price
Held after
0.00
Exercisable
—
Series C Preferred Stock
Common Stock
665.15K shares
Shares
−6.18M
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Direct | Common Stock2.31M shares | 8/6/2026 | C · Conversion | −21.48M | — | 0.00 | |
| Series B Preferred Stock Direct | Common Stock822K shares | 8/6/2026 | C · Conversion | −7.64M | — | 0.00 | |
| Series C Preferred Stock Direct | Common Stock665.15K shares | 8/6/2026 | C · Conversion | −6.18M | — | 0.00 |